Cargando…

Microvascular Changes After Conbercept Intravitreal Injection of PDR With or Without Center-Involved Diabetic Macular Edema Analyzed by OCTA

PURPOSE: To investigate the intravitreal injection of conbercept as a treatment strategy for proliferative diabetic retinopathy (PDR) with or without center-involved diabetic macular edema (CI-DME) and evaluate its effect on the microvascular changes in the eyes. METHODS: In this prospective study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wei, Feng, Meng, Liu, Tingting, Wang, Qingxu, Wang, Wenqi, Xie, Xiao, Li, Wenhao, Guan, Jitian, Ma, Zhongyu, Liu, Tong, Zhou, Qingjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982760/ https://www.ncbi.nlm.nih.gov/pubmed/35391880 http://dx.doi.org/10.3389/fmed.2022.797087

Ejemplares similares

Evaluation of the efficacy of Conbercept in the treatment of diabetic macular edema based on OCTA
por: Ba, Teer, et al.
Publicado: (2020)

Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion
por: Song, Wenqi, et al.
Publicado: (2020)

EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION
por: Sun, Zuhua, et al.
Publicado: (2017)

Clinical Observation of Phacoemulsification Combined with Intravitreal Injection of Conbercept in Cataract Patients with Diabetic Macular Edema
por: Wang, Jing, et al.
Publicado: (2021)

Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions
por: Ding, Xiaoxia, et al.
Publicado: (2022)

Switching to Conbercept in Diabetic Macular Edema After Unsatisfactory Response to Previous Intravitreal Injection of Ranibizumab
por: Xing, Peiyu, et al.
Publicado: (2023)

Comparison of the Efficacy and Safety of Intravitreal Conbercept with Intravitreal Ranibizumab for Treatment of Diabetic Macular Edema: A Meta-Analysis
por: Sun, Xiaolei, et al.
Publicado: (2020)

Intravitreal injection of conbercept combined with retinal photocoagulation on macular edema secondary to branch retinal vein occlusion
por: Wang, Bing, et al.
Publicado: (2020)

Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema
por: Wei, Qingquan, et al.
Publicado: (2019)

The Analysis of Correlative Factors of Visual Acuity with Intravitreal Conbercept Injection in Macular Edema Associated with Branch Retinal Vein Occlusion
por: Luo, Wenjuan, et al.
Publicado: (2018)

Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study
por: Zhang, Wei, et al.
Publicado: (2021)

Changes in Macular Perfusion After ILUVIEN® Intravitreal Implant for Diabetic Macular Edema: An OCTA Study
por: Brambati, Maria, et al.
Publicado: (2022)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
por: Cai, Siwei, et al.
Publicado: (2018)

Conbercept and Retinal Photocoagulation in the treatment of Diabetic Macular Edema
por: Meng, Weizhe, et al.
Publicado: (2019)

One-year outcomes of novel VEGF decoy receptor therapy with intravitreal conbercept in diabetic retinopathy-induced macular edema
por: Zhou, Qingyun, et al.
Publicado: (2019)

Intravitreal Conbercept with Grid/Focal Photocoagulation for the Treatment of Diabetic Macular Edema: A Systematic Review and Meta-Analysis
por: Sun, Xiaoyan, et al.
Publicado: (2022)

Correction to: Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study
por: Zhang, Wei, et al.
Publicado: (2021)

Evaluation of short-term intraocular pressure changes after intravitreal injection of Conbercept in patients with diabetic macular edema
por: Hu, Yunyan, et al.
Publicado: (2022)

Intravitreal conbercept for branch retinal vein occlusion induced macular edema: one initial injection versus three monthly injections
por: Chen, X., et al.
Publicado: (2020)

Intravitreal Conbercept Injection with and without Grid Laser Photocoagulation in the Treatment of Diffuse Diabetic Macular Edema in Real-Life Clinical Practice
por: Xu, Yule, et al.
Publicado: (2016)

Short-term effect of intravitreal conbercept injection on major and macular branch retinal vein occlusion
por: Tao, Yuan, et al.
Publicado: (2019)

Retinal Microvascular Changes after Intravitreal Triamcinolone Acetonide in Diabetic Macular Edema
por: Kato, Fusae, et al.
Publicado: (2023)

One-Year Effectiveness Study of Intravitreously Administered Conbercept(®) Monotherapy in Diabetic Macular Degeneration: A Systematic Review and Meta-Analysis
por: Wang, Heping, et al.
Publicado: (2020)

Analysis on short-term change of macular function and the correlates after intravitreal conbercept for CRVO-ME
por: Wang, Yun-Chang, et al.
Publicado: (2022)

Correlation of retinal layer changes with vision gain in diabetic macular edema during conbercept treatment
por: Xu, Yupeng, et al.
Publicado: (2019)

The Efficacy of Intravitreal Conbercept for Chronic Central Serous Chorioretinopathy
por: Mao, Jianbo, et al.
Publicado: (2019)

Cost-effectiveness of intravitreal conbercept versus other treatments for wet age-related macular degeneration
por: Chen, Rui, et al.
Publicado: (2020)

Full-Thickness Macular Hole After Intravitreal Conbercept Injection in Branch Retinal Vein Occlusion
por: Xie, Pinxue, et al.
Publicado: (2023)

Hyperreflective foci in OCT image as a biomarker of poor prognosis in diabetic macular edema patients treating with Conbercept in China
por: Liu, Shulin, et al.
Publicado: (2019)

Conbercept combined with laser photocoagulation in the treatment of diabetic macular edema and its influence on intraocular cytokines
por: Zhan, Hui-Qin, et al.
Publicado: (2023)

Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema
por: Dubey, Arvind Kumar, et al.
Publicado: (2016)

Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China: Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
por: Nie, Xin, et al.
Publicado: (2021)

Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema
por: Huang, Yikeng, et al.
Publicado: (2022)

Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept
por: Zhang, Qi, et al.
Publicado: (2021)

IVTA as Adjunctive Treatment to PRP and MPC for PDR and Macular Edema: A Meta-Analysis
por: Liu, Lei, et al.
Publicado: (2012)

Clinical outcomes of 1 + PRN and 3 + Q3M regimens of intravitreal conbercept injection for exudative age-related macular degeneration
por: Gao, Lei, et al.
Publicado: (2020)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6op533a02js043m8rh900oeag1